| Name | Title | Contact Details |
|---|
Esperance Pharmaceuticals, Inc. is developing a new class of targeted oncology products that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cancer cell surface. The novel product candidates destroy dividing and non-dividing cancer cells including those known to be resistant to chemotherapeutics.
TRx Pharma is a Chapel Hill, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cadila Pharmaceuticals - CPL, Inc. is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Meda is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At iA, we partner with our customers to transform pharmacy by deepening the patient-pharmacist relationship, enhancing patient safety and increasing operational efficiency.